沈阳扁平疣医院价格贵不沈阳那个医院治疗干癣好呢,沈阳扁平疣应该如何治疗,沈阳市脂溢性脱发哪家医院比较好,生殖器疱疹沈阳哪里治疗,沈阳治疗腋臭手术费用,沈阳哪个医院治疗青青痘好,沈阳那家医院看皮肤科比较好

NEW YORK, Oct. 14 (Xinhua) -- The iPhone 4S went on sale at Apple store on the Fifth Avenue of Manhattan in New York early Friday.An Apple store worker said people were waiting outside the store around 3 p.m. Thursday and underwent an overnight rain for an early purchase of the smart phone which started sale at 8 a.m. Friday.About 200 people were seen lining up outside the store and some of them said they would like to pay tribute to Steve Jobs, Apple's longtime CEO who died of pancreatic cancer at the age of 56 on Oct. 5."I'm a Steve's fan, iPhone 4S is the best of Steve's work. I am not going to buy iPhone 5,"Jim Bedford, who is in his 30s, said. "Maybe this is my last iPhone," he added.People left a Steve's picture, flowers and apples on the sidewalk to pay respect to Apple's co-founder. Some apples were seen inscribed such words as "Nice job" and "We will always remember you."Tom White, 50, said he had iPhone 1 and 3 and "now is the time to change a new one."The iPhone 4S is operated seven times faster than their predecessor and features an upgraded camera. Apple reported more than 1 million pre-orders for the iPhone 4S, breaking a mark set by last year's model. The phone also went on sale Friday in six other countries -- Britain,Germany,France,Australia, Canada and Japan.

BEIJING, Oct. 11 (Xinhuanet) -- For women, chocolate consumption needs to be high, which can lower stroke risk, researchers from the Karolinska Institute, Sweden, reported in the Journal of the American College of Cardiology. The consumption of chocolate has been demonstrated to reduce diastolic and systolic blood pressure in randomized, short-term trials. Chocolate has also been shown to improve endothelial and platelet function, and to improve insulin resistance.Susanna Larsson Ph.D. and the team conducted the research on the Swedish Mammography Cohort's 33,372 adult females aged from 49 to 83 years without history of stroke, coronary heart disease, stroke, or diabetes.They found those who ate at least two chocolate bars each week appeared to have a 20 percent lower risk of stroke, compared to those of the same age and weight who rarely or never ate chocolate. But, they found, it was only those in the highest quartile of chocolate consumption who had a significant drop in stroke risk.The researchers explained that cocoa has flavonoids - powerful antioxidants that can suppress LDL, low-density lipoprotein, that can cause stroke and other cardiovascular diseases.

SEOUL, Jan. 6 (Xinhua) -- LG Electronics, the world's No.2 TV maker, said Friday that it will showcase a smart TV that runs Google TV during next week's Consumer Electronics Show (CES) in Las Vegas.The LG-made Google TV powered by Google's Android operating system (OS) will be unveiled next Monday at the U.S. consumer electronics fair in Las Vegas, according to an e-mailed statement by LG.The Internet TV will offer its Android-based user interface, enabling consumers to enjoy web browsing and social networking, LG said. Multi-taking will also be available as the Internet surfing, social networking and TV functions can be run simultaneously.LG's three-dimensional (3D) technology will be available through its Google TV. With a single click of a remote controller, any two-dimensional (2D) program or movie can be viewed in 3D due to the built-in 2D to 3D conversion engine."Through Google TV, LG has merged Google's established Android operating system with LG's proven 3D and Smart TV technologies, offering consumers a new and enthralling TV experience," said Havis Kwon, chief executive of LG Electronics' home entertainment business.

BEIJING, Oct. 18 (Xinhuanet) -- NASA recently unveiled its new rocket design, named Space Launch System (SLS), according to media reports.The rocket will make its first unmanned flight in 2017, and the flight with astronauts aboard won't happen until 2021, according to NASA's plan.The new rocket was 320 feet in length (the space shuttle was 184 feet on the launch pad), 5.5 million pounds in weight, and with the capacity of holding four astronauts at the top speed of 25,000 miles per hour, Washington Post reported Tuesday.Compared with space shuttle and other predecessors, the new rocket will aim for much farther destinations into the space with its most powerful engine ever built, according to the plan."We're investing in technologies to live and work in space, and it sets the stage for visiting asteroids and Mars," the NASA administrator Charles Bolden briefed the media at a news conference in Washington.NASA expected to devote 3 billion U.S. dollars a year to the effort, or a total of about 18 billion U.S. dollars over the next six years, said William Gerstenmaier, the agency’s associate administrator for human exploration.The current financial condition of U.S. may slow down the pace of progress, which will be much slower than NASA's Apollo heyday in the 1960s.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze."The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.Side effects associated with Erwinaze treatment include serious allergic reactions, inflammation of the pancreas, high blood levels of liver enzymes, blood clotting, bleeding, nausea, vomiting and high blood sugar.